CUSIP: 73730P108
What is CUSIP 73730P108?
CUSIP 73730P108 identifies PSTX - POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$308,000 | 0 | |
| 2025 Q1 | 100,000 | $308,000 | -$512,769,976 | $3.08 | 1 |
| 2024 Q4 | 53,970,727 | $518,070,752 | +$17,008,807 | $9.60 | 114 |
| 2024 Q3 | 53,512,171 | $153,042,595 | +$889,907 | $2.86 | 94 |
| 2024 Q2 | 52,954,774 | $154,591,146 | -$128,086 | $2.92 | 90 |
| 2024 Q1 | 52,747,602 | $168,247,853 | +$23,931,180 | $3.19 | 90 |
| 2023 Q4 | 45,227,069 | $151,964,876 | +$388,861 | $3.36 | 90 |
| 2023 Q3 | 45,211,925 | $107,601,397 | +$2,937,881 | $2.38 | 85 |
| 2023 Q2 | 44,463,763 | $78,239,697 | -$5,736,756 | $1.76 | 91 |
| 2023 Q1 | 44,145,641 | $135,966,651 | +$3,079,454 | $3.08 | 101 |
| 2022 Q4 | 42,639,196 | $225,970,611 | +$18,484,174 | $5.30 | 88 |
| 2022 Q3 | 40,082,757 | $141,733,596 | +$62,472,178 | $3.53 | 66 |
| 2022 Q2 | 22,502,781 | $58,056,750 | -$5,315,127 | $2.58 | 51 |
| 2022 Q1 | 24,182,970 | $108,362,581 | -$12,481,973 | $4.48 | 62 |
| 2021 Q4 | 25,853,738 | $176,062,275 | -$2,997,826 | $6.81 | 59 |
| 2021 Q3 | 26,151,081 | $190,704,000 | -$17,048,693 | $7.29 | 62 |
| 2021 Q2 | 27,875,232 | $279,302,000 | -$10,459,200 | $10.02 | 69 |
| 2021 Q1 | 28,928,358 | $276,249,644 | +$21,624,136 | $9.55 | 62 |
| 2020 Q4 | 26,347,216 | $288,434,000 | +$15,183,869 | $10.97 | 55 |
| 2020 Q3 | 25,108,950 | $217,383,620 | +$217,383,620 | $8.87 | 51 |